The most expensive part of a hospital bill may never touch the hospital at all. A patient admitted for care has no way of knowing whether the price on a medical consumable reflects its actual cost or a markup fixed long before it ever reached the ward. That gap in information is, at its core, a public health issue. A survey of hospital consumables in Maharashtra found an IV infusion set with a trade price of ₹11.05 carrying a printed MRP of ₹325 ; a markup of 2,841%. A syringe procured at ₹6.75 carried an MRP of ₹57.20. A catheter procured at ₹29.41 carried an MRP of ₹310. These are not elective purchases. Patients cannot compare prices, seek alternatives, or question a number printed on a box while receiving care and the MRP itself is often fixed upstream by manufacturers and distributors, disconnected from the trade price by a wide, unexplained margin. The result is a system where the party bearing the cost has the least information to evaluate it. The regulatory gap is structural: scheduled medicines are capped under the Drugs (Prices Control) Order, 2013. Most medical devices and consumables are not leaving both the pricing and the information around it almost entirely unmonitored. A review of these findings and clear guidelines on the permissible gap between trade procurement price and declared MRP have been recommended to the Department of Pharmaceuticals and the NPPA ; a step toward closing not just a pricing gap, but the information gap patients are left to bear alone. #PublicHealth #GoodGovernance #Leadership #TukaramMundhe moneycontrol.com/news/busine…

In case anyone is concerned abt stray dog menace, pls read this thread. Delhi HC has appointed Maneka Gandhi's secratary as amicus, & ordered that all dogs should be released back to the area they were captured from. It was noted that noone has come forward to oppose this.

Human haters shall call this video fake.

If you pay organizations per homeless person, you get more homeless people and the NGOs fight hard to maximize the homeless population. Whatever you incentivize will happen.

Man risks life to save his car from flood 🥺

India features in the list of 6 countries in the world where stray dogs are in crisis 1. India 2. Pakistan 3. Kazakhstan 4. Turkey 5. Romania 6. Morocco CRISIS ZONES Dogs are facing an active systemic threat through collection, confinement, culling, euthanasia policies, inadequate capacity, or major policy changes affecting large numbers of dogs. What a shame that India is on the list. No longer a Nation of Ahimsa. @RajatSharmaLive @PhaedraXTeddy @DogDeskAction

BIG NEWS 🚨 Annamalai submits a five-page resignation letter. He will form a new party. He envisions a political platform that combines Tamil identity with a national outlook. There was a massive craze for him during his yatra. He is reportedly planning to launch a new regional political party with what associates describe as a "Nationalist", "Secular" and "Tamil-first" outlook.

Both men said “I can’t breathe”, but only one man’s death was covered relentlessly by the media. The only conclusion that can be drawn is that the legacy mainstream media is incredibly, hatefully racist against Whites.

If you pay organizations per homeless person, you get more homeless people and the NGOs fight hard to maximize the homeless population. Whatever you incentivize will happen.

भारत में रेबीज़ इंडस्ट्री से मुख्य लाभार्थी हैं: फार्मा कंपनियां: Serum Institute of India (सबसे बड़ा वैक्सीन मेकर), Bharat Biotech (IndiRab), Zydus Lifesciences, Cadila, Sanofi Pasteur (Verorab) - ये वैक्सीन बेचकर ₹125 करोड़+ कमाते हैं। एनजीओ/लॉबी: People for Animals (PFA), Blue Cross of India, Mission Rabies (Merck से फंडिंग) - स्ट्रे डॉग प्रोटेक्शन से फंडिंग मिलती है, जो समस्या बढ़ाती है। वकील: Abhishek Manu Singhvi, Kapil Sibal (स्ट्रे डॉग लॉबी रिप्रेजेंट)। ये स्ट्रे डॉग्स बढ़ाकर वैक्सीन डिमांड बनाए रखते हैं।